Gene · 27036
Papers1,589
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,589
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Deficient extravillous trophoblast invasion caused by impaired sialylation-Siglec-7 interaction contributes to recurrent pregnancy loss. | Cell Death Dis | 2026 | 41771823 | PubTator, text mining | PubMed |
| Memory T cell rapid recall is driven by memory-specific AP-1 recruitment determined by epigenome and co-factor interactions. | bioRxiv | 2026 | 41757074 | PubTator, text mining | PubMed |
| Microbiome-Genome Crosstalk in Colorectal Cancer: Colibactin Signatures and Fusobacterium nucleatum in Epidemiology, Driver Selection, and Translation. | Int J Mol Sci | 2026 | 41752202 | PubTator, text mining | PubMed |
| Innovative approaches targeting innate immune cells to promote organ transplant tolerance. | Front Transplant | 2026 | 41737588 | PubTator, text mining | PubMed |
| Editorial: Molecular and functional profiling in breast cancer: implications for hereditary and sporadic cases. | Front Oncol | 2026 | 41737489 | PubTator, text mining | PubMed |
| Siglec-7 Links Mitochondrial Dynamics to Megakaryocytic Differentiation. | Stem Cells Dev | 2026 | 41698887 | PubTator, text mining | PubMed |
| Cell-derived Nanoparticles Provide a Robust Platform to Manufacture Therapeutic T cells. | Res Sq | 2026 | 41674825 | PubTator, text mining | PubMed |
| Suppression of interferon signaling via small-molecule modulation of TFAM. | Elife | 2026 | 41649246 | PubTator, text mining | PubMed |
| Polysialylated CD56 drives immune evasion in clear cell renal cell carcinoma via engagement of the Siglec-7 checkpoint on CD8+ T cells. | Int Immunopharmacol | 2026 | 41643265 | PubTator, text mining | PubMed |
| Discovery and preclinical evaluation of monoclonal antibodies and bispecific engagers targeting the NKG2A inhibitory receptor. | Sci Adv | 2026 | 41637511 | PubTator, text mining | PubMed |
| Spaceflight alters the immune regulatory functions of neutrophil granulocytes on T lymphocytes. | iScience | 2026 | 41531729 | PubTator, text mining | PubMed |
| Polysialic acid-Siglec immune checkpoints of microglia and macrophages: Perspectives for therapeutic intervention. | Neural Regen Res | 2026 | 39688555 | PubTator, text mining | PubMed |
| Macrophage-centered therapy strategies: A promising weapon in cancer immunotherapy. | Asian J Pharm Sci | 2025 | 41809255 | PubTator, text mining | PubMed |
| Morphometric prediction of mesenchymal stromal cell-like immunosuppressive capacity of human hair follicle dermal sheath cup cells: an implication for regenerative medicine in hair loss diseases. | Stem Cell Res Ther | 2025 | 41250241 | PubTator, text mining | PubMed |
| A Novel Peptide-Anchoring Method to Functionalize Gelatin Hydrogels with Antibodies via a Noncovalent Interaction. | ACS Omega | 2025 | 41244465 | PubTator, text mining | PubMed |
| An ultrasensitive and modular platform to detect Siglec ligands and control immune cell function. | Sci Adv | 2025 | 41223255 | PubTator, text mining | PubMed |
| From plasma proteomics Mendelian randomization to neuropathological validation: The potential role of CTSH-GRN-TMEM106B and TREM2-IL-34 networks of microglia in Alzheimer's disease. | Eur J Pharmacol | 2025 | 41138838 | PubTator, text mining | PubMed |
| Surfaceome CRISPR activation screening uncovers ligands regulating tumor sensitivity to NK cell killing. | bioRxiv | 2025 | 41000986 | PubTator, text mining | PubMed |
| A phosphoramidate modification of FUDR, NUC-3373, causes DNA damage and DAMPs release from colorectal cancer cells, potentiating lymphocyte-induced cell death. | PLoS One | 2025 | 40956795 | PubTator, text mining | PubMed |
| Abstracts from the 10th Atlantic Corridor Medical Student Research Conference 2024. | BMC Proc | 2025 | 40931364 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/27036/papers?page=2